Tag: CEMI

Yesterday’s Hitters, Today’s New Ideas

Tuesday’s Big Plays:

Things continued to go rather well for us on the options trading front yesterday. We stick our necks out to come up with quality trading ideas on a daily basis, and while it can sometimes prove challenging, we always seem to get the job done in respectable fashion. Of course it helps significantly that the markets have been especially volatile, as they have been this earnings season, to ratchet up the opportunities for daytraders. We hit on three out of the four ideas in which we were interested.

The potential plays we targeted in yesterday morning’s premarket report that went on to record big gains were the UBER Weekly $26.50-27.50 Calls, the MAR Weekly $160-162.50 Calls, and the CAT Weekly $192.50-187.50 Puts. Lets have a look at the type of intraday movement they provided for us during yesterday’s session.

UBER Weekly $26.50-27.50 Calls
$26.50: 1.40-2.98 (+113%)
$27: 1.14-2.60 (+128%)
$27.50: .89-2.15 (+142%)
_____

MAR Weekly $160-162.50 Calls
$160: 1.05-3.40 (+224%)
$162.50: .52-2.10 (+320%)
_____

CAT Weekly $192.50-187.50 Puts 
$192.50: 4.95-9.50 (+92%)
$190: 3.40-6.87 (+102%)
$187.50: 2.20-5.15 (+134%)

Fresh Options Ideas:
PYPL Weekly $98-101 Calls
SBUX Weekly $84-86 Calls
MRNA Weekly $162.50-167.50 Calls

Extended Watchlist: 
EAR, AMTD, APDN, HSDT, CEMI, TOUR, PSTX, OPTT, SIRC, IGEX, OZSC, EFSH, TWOH

MRNA Calls Post Multi-Bag Runs & More

Moderna Inc. MRNA – Options Explosion:

Our decision to feature MRNA Calls in Friday morning’s premarket report turned out to be an absolute stroke of genius, and opened the door on some truly incredible intraday trading opportunities.

We were zeroed in on the MRNA 12/03 $320-325 Calls, and ended up witnessing one of the largest single session moves made by any of our picks from the whole of 2021, in the $325’s. The stock itself ran sharply, perhaps with the aid of coronavirus anxiety stoked by the emergence of a new variant. The run enabled the following fantastic intraday chances for our readers:

MRNA 12/03 $320-325 Calls
$320: 8.00-39.07 (+388%)
$325: 1.30-36.00 (+2669%)

We’ll go ahead and roll up our potential strike area to include the MRNA Weekly $355-365 Calls on the chance that MRNA maintains its this incredible momentum.
_____

Fresh Options Ideas:
SPY 11/29 $463-464 Calls
LI Weekly $33-35 Calls

Faraday Future Intelligent Electric, Inc. FFIE – Bottom-Watch:     

In the midst of tax loss selling season, we’re always going to be on the lookout for potential bargains, and we believe we may have found one in FFIE. As we’ve pointed out on the following chart, the stock has been beaten up considerably. It’s extremely oversold at the moment, and we’re going to want to monitor it for a recovery in the weeks and months ahead.

We’ve also gotten some impressive new highs in a couple of the plays we were highlighting on Friday.

iSpecimen, Inc. ISPC 
Alert: November 22nd
Range: 9.01-24.67
Gained: +174%
_____

Biofrontera Inc. BFRI
Alert: November 24th
Range: 4.60-9.49
Gained: +106%

Extended Watchlist:
NRXP, PTPI, APDN, PRPO,KRYS, PTN, YCBD, CEMI, TOMDF, OPTI, TIPS, IFXY, GOFF

MDGS News, Options Plays & More

Medigus Ltd. MDGS – News Alert:

Our first order of business today is to go over the fresh news to hit the wires this morning for MDGS, One of the companies in which MDGS owns a controlling stake, is reporting that its Capture and Contain (C&C™) platform technology has been found effective in reducing the risk of infection with the H1N1 virus. Polyrizon has already reported similar results with coronavirus.

MDGS was the subject a special report we published on Monday morning. We’d suggest any of our readers who may have missed it, click here and go check it out. The stock has established higher lows each session this week, and it seems we timed the bottom with striking accuracy. Considering the frequency with which promising developments have been occurring for MDGS and its interests, like Polyrizon, we’re eager to see where this stock can go from here.
_____

OMER, Israel, Aug. 27, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd., a privately held company which Medigus owns 35.86% of its share capital, presented pre-clinical data showing that its Capture and Contain (C&C™) platform technology has the potential to reduce the risk of an infection with Influenza virus H1N1 and may potentially also treat additional Cold viruses.(>>Read Full PR)
_____

To Learn More about MDGS Please Visit:
Medigus.com/Investor-Relations

Options Review:

Two out of yesterday’s three fresh options ideas were quick strike post-earnings plays, the  ULTA Weekly $405-415 Calls and the CRM Weekly $262.50-270 Calls, and they both provided ample opportunity for solid daily gains.

ULTA Weekly $405-415 Calls
$405: 2.66-8.58 (+222%)
$410: 2.51-6.76 (+169%)
$415: 1.88-8.72 (+364%)
______

CRM Weekly $262.50-270 Calls
$262.50: 7.74-12.95 (+67%)
$265: 5.92-10.55 (+78%)
$267.50: 4.60-8.10 (+76%)
$270: 3.31-5.92 (+79%)
_____

Fresh Options Ideas:
HIBB 09/17 $100-105 Calls
GPS Weekly $27-28.50 Calls*
WDAY Weekly $255-270*

*Please don’t attempt to trade weekly options on a Friday unless you are an experienced trader with access to disposable funds!

Extended Watchlist:
SPRT, NURO, RNXT, CEMI, NNA, PRFX, CLNV, BRBP, ICOA, SRCO, BRNE